AAAAAA

   
Results: 1-24 |
Results: 24
A PATIENT-ORIENTED APPROACH TO TREATMENT OF MYELODYSPLASTIC SYNDROMES
Authors: CAZZOLA M ANDERSON JE GANSER A HELLSTROMLINDBERG E
Citation: M. Cazzola et al., A PATIENT-ORIENTED APPROACH TO TREATMENT OF MYELODYSPLASTIC SYNDROMES, Haematologica, 83(10), 1998, pp. 910-935
TREATMENT OF LONG-TERM ANOREXIA AND NAUSEA AFTER STEM-CELL TRANSPLANTATION WITH LOW-DOSE OCTREOTIDE
Authors: NORDESJO G LJUNGMAN P BJORKSTRAND B LINDBERG G HELLSTROMLINDBERG E
Citation: G. Nordesjo et al., TREATMENT OF LONG-TERM ANOREXIA AND NAUSEA AFTER STEM-CELL TRANSPLANTATION WITH LOW-DOSE OCTREOTIDE, Bone marrow transplantation, 21, 1998, pp. 312-312
EFFECTS OF FAS AND CASPASE INTERACTION ON APOPTOSIS AND PROLIFERATIONIN MYELODYSPLASTIC BONE-MARROW
Authors: HELLSTROMLINDBERG E FORSBLOM AM SYRUCKOVA Z CHRISTENSEN B FADEEL B ZHIVOTOVSKY B
Citation: E. Hellstromlindberg et al., EFFECTS OF FAS AND CASPASE INTERACTION ON APOPTOSIS AND PROLIFERATIONIN MYELODYSPLASTIC BONE-MARROW, British Journal of Haematology, 102(1), 1998, pp. 27-27
P39 TSUGANE CELL-LINE AS A MODEL FOR APOPTOSIS IN MDS/
Authors: HASSAN Z FADEEL B ZHIVOTOVSKY B FORSBLOM AM HELLSTROMLINDBERG E
Citation: Z. Hassan et al., P39 TSUGANE CELL-LINE AS A MODEL FOR APOPTOSIS IN MDS/, British Journal of Haematology, 102(1), 1998, pp. 28-29
TREATMENT OF ANEMIA IN MYELODYSPLASTIC SYNDROMES WITH GRANULOCYTE-COLONY-STIMULATING FACTOR PLUS ERYTHROPOIETIN - RESULTS FROM A RANDOMIZEDPHASE-II STUDY AND LONG-TERM FOLLOW-UP OF 71 PATIENTS
Authors: HELLSTROMLINDBERG E AHLGREN T BEGUIN Y CARLSSON M CARNESKOG J DAHL IM DYBEDAL I GRIMFORS G KANTERLEWENSOHN L LINDER O LUTHMAN M LOFVENBERG E NILSSONEHLE H SAMUELSSON J TANGEN JM WINQVIST I OBERG G OSTERBORG A OST A
Citation: E. Hellstromlindberg et al., TREATMENT OF ANEMIA IN MYELODYSPLASTIC SYNDROMES WITH GRANULOCYTE-COLONY-STIMULATING FACTOR PLUS ERYTHROPOIETIN - RESULTS FROM A RANDOMIZEDPHASE-II STUDY AND LONG-TERM FOLLOW-UP OF 71 PATIENTS, Blood, 92(1), 1998, pp. 68-75
MORPHOLOGICAL-CHANGES AND APOPTOSIS IN BONE-MARROW FROM PATIENTS WITHMYELODYSPLASTIC SYNDROMES TREATED WITH GRANULOCYTE-CSF AND ERYTHROPOIETIN
Authors: HELLSTROMLINDBERG E KANTERLEWENSOHN L OST A
Citation: E. Hellstromlindberg et al., MORPHOLOGICAL-CHANGES AND APOPTOSIS IN BONE-MARROW FROM PATIENTS WITHMYELODYSPLASTIC SYNDROMES TREATED WITH GRANULOCYTE-CSF AND ERYTHROPOIETIN, Leukemia research, 21(5), 1997, pp. 415-425
ERYTHROID RESPONSE TO TREATMENT WITH G-CSF PLUS ERYTHROPOIETIN FOR THE ANEMIA OF PATIENTS WITH MYELODYSPLASTIC SYNDROMES - PROPOSAL FOR A PREDICTIVE MODEL
Authors: HELLSTROMLINDBERG E NEGRIN R STEIN R KRANTZ S LINDBERG G VARDIMAN J OST A GREENBERG P
Citation: E. Hellstromlindberg et al., ERYTHROID RESPONSE TO TREATMENT WITH G-CSF PLUS ERYTHROPOIETIN FOR THE ANEMIA OF PATIENTS WITH MYELODYSPLASTIC SYNDROMES - PROPOSAL FOR A PREDICTIVE MODEL, British Journal of Haematology, 99(2), 1997, pp. 344-351
G-CSF INFLUENCE ON APOPTOSIS INDUCED BY ATRA AND VP-16 IN P39 CELL-LINE
Authors: SYRUCKOVA Z FORSBLOM A HELLSTROMLINDBERG E
Citation: Z. Syruckova et al., G-CSF INFLUENCE ON APOPTOSIS INDUCED BY ATRA AND VP-16 IN P39 CELL-LINE, Blood, 90(10), 1997, pp. 3486-3486
EFFECTS OF G-CSF, EPO, SCF, ATRA AND THE CD-95 BLOCKING ANTIBODY F(AB')2 ON IN-VITRO APOPTOSIS AND PROLIFERATION IN MYELODYSPLASTIC (MDS) BONE-MARROW
Authors: HELLSTROMLINDBERG E FORSBLOM AM SYRUCKOVA Z CHRISTENSEN B
Citation: E. Hellstromlindberg et al., EFFECTS OF G-CSF, EPO, SCF, ATRA AND THE CD-95 BLOCKING ANTIBODY F(AB')2 ON IN-VITRO APOPTOSIS AND PROLIFERATION IN MYELODYSPLASTIC (MDS) BONE-MARROW, Blood, 90(10), 1997, pp. 2322-2322
ANALYSIS OF CD34-POSITIVE CELLS IN BONE-MARROW FROM PATIENTS WITH MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID-LEUKEMIA AND IN NORMAL INDIVIDUALS - A COMPARISON BETWEEN FACS ANALYSIS AND IMMUNOHISTOCHEMISTRY
Authors: KANTERLEWENSOHN L HELLSTROMLINDBERG E KOCK Y ELMHORNROSENBORG A OST A
Citation: L. Kanterlewensohn et al., ANALYSIS OF CD34-POSITIVE CELLS IN BONE-MARROW FROM PATIENTS WITH MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID-LEUKEMIA AND IN NORMAL INDIVIDUALS - A COMPARISON BETWEEN FACS ANALYSIS AND IMMUNOHISTOCHEMISTRY, European journal of haematology, 56(3), 1996, pp. 124-129
EFFECTS OF ALL-TRANS-RETINOIC ACID (ATRA), GRANULOCYTE-CSF (G-CSF) AND ERYTHROPOIETIN (EPO) ON IN-VITRO APOPTOSIS AND PROLIFERATION IN MYELODYSPLASTIC BONE-MARROW
Authors: HELLSTROMLINDBERG E FORSBLOM AM
Citation: E. Hellstromlindberg et Am. Forsblom, EFFECTS OF ALL-TRANS-RETINOIC ACID (ATRA), GRANULOCYTE-CSF (G-CSF) AND ERYTHROPOIETIN (EPO) ON IN-VITRO APOPTOSIS AND PROLIFERATION IN MYELODYSPLASTIC BONE-MARROW, Blood, 88(10), 1996, pp. 371-371
TREATMENT OF THE ANEMIA IN MDS WITH G-CSF AND EPO - FINAL REPORT FROMA RANDOMIZED PHASE-II STUDY
Authors: HELLSTROMLINDBERG E TANGEN JM GRIMFORS G LINDEMALM C CARLSSON M OBERG G LOWENBERG E LINDER O DYBEDAL I DAHL IM NILSSONEHLE H AHLGREN T WINQUIST I CARNESKOG J LUTHMAN M
Citation: E. Hellstromlindberg et al., TREATMENT OF THE ANEMIA IN MDS WITH G-CSF AND EPO - FINAL REPORT FROMA RANDOMIZED PHASE-II STUDY, Blood, 88(10), 1996, pp. 1805-1805
PERIPHERAL-BLOOD NEUTROPHIL MORPHOLOGY REFLECTS BONE-MARROW DYSPLASIAIN MYELODYSPLASTIC SYNDROMES
Authors: WIDELL S HELLSTROMLINDBERG E KOCK Y LINDBERG M OST A HAST R
Citation: S. Widell et al., PERIPHERAL-BLOOD NEUTROPHIL MORPHOLOGY REFLECTS BONE-MARROW DYSPLASIAIN MYELODYSPLASTIC SYNDROMES, American journal of hematology, 49(2), 1995, pp. 115-120
RECOMBINANT ERYTHROPOIETIN FOR MYELODYSPLASTIC SYNDROMES
Authors: HELLSTROMLINDBERG E
Citation: E. Hellstromlindberg, RECOMBINANT ERYTHROPOIETIN FOR MYELODYSPLASTIC SYNDROMES, British Journal of Haematology, 91(1), 1995, pp. 257-258
EFFICACY OF ERYTHROPOIETIN IN THE MYELODYSPLASTIC SYNDROMES - A METAANALYSIS OF 205 PATIENTS FROM 17 STUDIES
Authors: HELLSTROMLINDBERG E
Citation: E. Hellstromlindberg, EFFICACY OF ERYTHROPOIETIN IN THE MYELODYSPLASTIC SYNDROMES - A METAANALYSIS OF 205 PATIENTS FROM 17 STUDIES, British Journal of Haematology, 89(1), 1995, pp. 67-71
ERYTHROPOIETIC EFFECTIVENESS AND APOPTOSIS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS) TREATED WITH G-CSF AND EPO
Authors: KANTER L HELLSTROMLINDBERG E KOCK Y RODENSJO M OST A
Citation: L. Kanter et al., ERYTHROPOIETIC EFFECTIVENESS AND APOPTOSIS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS) TREATED WITH G-CSF AND EPO, Blood, 86(10), 1995, pp. 1339-1339
EFFICACY OF G-CSF AND EPO ON THE ANEMIA IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS)
Authors: HELLSTROMLINDBERG E NEGRIN R STEIN R KRANTZ S VARDIMAN J OST A LINDBERG G GREENBERG P
Citation: E. Hellstromlindberg et al., EFFICACY OF G-CSF AND EPO ON THE ANEMIA IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS), Blood, 86(10), 1995, pp. 1340-1340
LOW-DOSE ARA-C IN MYELODYSPLASTIC SYNDROMES (MDS) AND ACUTE-LEUKEMIA FOLLOWING MDS - PROPOSAL FOR A PREDICTIVE MODEL
Authors: HELLSTROMLINDBERG E ROBERT KH GAHRTON G LINDBERG G FORSBLOM AM KOCK Y OST A
Citation: E. Hellstromlindberg et al., LOW-DOSE ARA-C IN MYELODYSPLASTIC SYNDROMES (MDS) AND ACUTE-LEUKEMIA FOLLOWING MDS - PROPOSAL FOR A PREDICTIVE MODEL, Leukemia & lymphoma, 12(5-6), 1994, pp. 343-351
G-CSF AND GM-CSF IN ONCOLOGY AND ONCOLOGICAL HEMATOLOGY
Authors: HARMENBERG J HOGLUND M HELLSTROMLINDBERG E
Citation: J. Harmenberg et al., G-CSF AND GM-CSF IN ONCOLOGY AND ONCOLOGICAL HEMATOLOGY, European journal of haematology, 52, 1994, pp. 1-28
SYNERGISTIC EFFECT OF G-CSF AND EPO ON THE ANEMIA IN PATIENTS WITH MDS - EVIDENCE FOR INCREASED ERYTHROPOIETIC EFFECTIVENESS RATHER THAN EXPANSION
Authors: HELLSTROMLINDBERG E CARLSSON M CARNESKOG J DAHL IM DYBEDAL I GRIMFORS G LINDEMALM C LINDER O LOFVENBERG E NILSSONEHLE H TANGEN JM TURESSON I WINQVIST I OBERG G BEGIN Y OST A
Citation: E. Hellstromlindberg et al., SYNERGISTIC EFFECT OF G-CSF AND EPO ON THE ANEMIA IN PATIENTS WITH MDS - EVIDENCE FOR INCREASED ERYTHROPOIETIC EFFECTIVENESS RATHER THAN EXPANSION, Blood, 84(10), 1994, pp. 10000317-10000317
A COMBINATION OF GRANULOCYTE-COLONY-STIMULATING FACTOR AND ERYTHROPOIETIN MAY SYNERGISTICALLY IMPROVE THE ANEMIA IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES
Authors: HELLSTROMLINDBERG E BIRGEGARD G CARLSSON M CARNESKOG J DAHL IM DYBEDAL I GRIMFORS G MERK K TANGEN JM WINQVIST I OST A
Citation: E. Hellstromlindberg et al., A COMBINATION OF GRANULOCYTE-COLONY-STIMULATING FACTOR AND ERYTHROPOIETIN MAY SYNERGISTICALLY IMPROVE THE ANEMIA IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES, Leukemia & lymphoma, 11(3-4), 1993, pp. 221-228
RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR PLUS RECOMBINANT-HUMAN-ERYTHROPOIETIN MAY IMPROVE ANEMIA IN SELECTED PATIENTS WITH MYELODYSPLASTIC SYNDROMES
Authors: HANSEN PB JOHNSEN HE HIPPE E HELLSTROMLINDBERG E RALFKIAER E
Citation: Pb. Hansen et al., RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR PLUS RECOMBINANT-HUMAN-ERYTHROPOIETIN MAY IMPROVE ANEMIA IN SELECTED PATIENTS WITH MYELODYSPLASTIC SYNDROMES, American journal of hematology, 44(4), 1993, pp. 229-236
VARIABLE GROWTH IN-VITRO OF CHROMOSOMALLY DIFFERENT STEM-CELLS IN MYELODYSPLASTIC SYNDROMES
Authors: SWOLIN B KRISTIANSEN IH RODJER S HELLSTROMLINDBERG E
Citation: B. Swolin et al., VARIABLE GROWTH IN-VITRO OF CHROMOSOMALLY DIFFERENT STEM-CELLS IN MYELODYSPLASTIC SYNDROMES, Leukemia research, 17(11), 1993, pp. 927-932
THE COMBINATION OF GRANULOCYTE-CSF AND ERYTHROPOIETIN (EPO) MAY SIGNIFICANTLY INCREASE THE HEMOGLOBIN LEVELS IN MDS-PATIENTS WITH NO RESPONSE TO EPO ALONE - REPORT FROM A RANDOMIZED PHASE-II TRIAL
Authors: HELLSTROMLINDBERG E CARLSSON M GRIMFORS G LINDEMALM C LOFVENBERG E TANGEN JM OST A
Citation: E. Hellstromlindberg et al., THE COMBINATION OF GRANULOCYTE-CSF AND ERYTHROPOIETIN (EPO) MAY SIGNIFICANTLY INCREASE THE HEMOGLOBIN LEVELS IN MDS-PATIENTS WITH NO RESPONSE TO EPO ALONE - REPORT FROM A RANDOMIZED PHASE-II TRIAL, Blood, 82(10), 1993, pp. 10000376-10000376
Risultati: 1-24 |